SciELO - Scientific Electronic Library Online

 
vol.34 issue1Does a greater training load increase the risk of injury and illness in ultramarathon runners? : A prospective, descriptive, longitudinal designChanging player behaviour in sport during the COVID-19 pandemic: Shake on it? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • On index processSimilars in Google

Share


South African Journal of Sports Medicine

On-line version ISSN 2078-516X
Print version ISSN 1015-5163

Abstract

D'ALTON, C et al. The effect of systematic exercise training on skeletal muscle strength in a patient with advanced inclusion body myositis: A case study. SA J. Sports Med. [online]. 2022, vol.34, n.1, pp.1-3. ISSN 2078-516X.  http://dx.doi.org/10.17159/2078-516x/2022/v34i1a13145.

Inclusion body myositis (IBM) is an inflammatory and degenerative autoimmune disease that targets specific muscle groups, causing severe muscle weakness. Exercise training is often contraindicated in myopathies as it may aggravate muscle damage and inflammation. Although some reported positive outcomes in muscle strength of early diagnosed IBM patients undergoing resistance training, there remains uncertainty as to whether exercise could be beneficial and safe in advanced stage IBM. Thus the aims of this research were to evaluate the safety and response of 16-weeks supervised resistance training on the health and muscle performance of an elderly participant diagnosed with advanced stage IBM. It was shown that the training had no adverse effects on the health of the patient. Muscle strength measured at eight weeks and on completion of the intervention, remained the same as at baseline. In conclusion, the exercise programme was found to be safe and seemed to maintain muscle strength in a patient with advanced stage IBM.

Keywords : myopathy; autoimmune disease; muscle weakness; resistance training.

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License